Top Markets
Coin of the day
NervGen Pharma Corp. NervGen Pharma Corp.

NervGen Pharma Corp.

NGEN
Rang in aandelen #16730
NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical... NervGen Pharma Corp., along with its affiliated entities, is a pharmaceutical company dedicated to discovering, advancing, and commercializing innovative drug therapies for neurological conditions involving nerve damage. Its flagship investigational therapy, NVG-291, is currently undergoing Phase 1 clinical trials, targeting significant neurological disorders such as spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. NervGen has also secured an exclusive licensing agreement with Case Western Reserve University. This partnership enables the company to research, advance, and commercialize a proprietary technology holding considerable therapeutic promise for SCI and a range of other nerve-related ailments. Established in 2017, NervGen Pharma Corp. maintains its headquarters in Vancouver, Canada.
Aandeelprijs
$3.78
Laatst gesynchroniseerd: 2026-03-17
Marktkapitalisatie
$276.54M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
45.53%
Land
CA
Handel NervGen Pharma Corp. (NGEN)

Categorie

Koersgeschiedenis voor NervGen Pharma Corp. (NGEN)
Hoogste slotkoers: $3.98 op 2026-03-01

Laagste slotkoers: $1.12 op 2019-03-01
Koersgeschiedenis van NervGen Pharma Corp. van 2019 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -18.31%
2025 129.35%
2024 42.00%
2023 15.06%
2022 -43.93%
2021 48.46%
2020 21.58%
2019 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$548.15 36.70%
US
$1.03K 45.33%
NL
$153.87 536.09%
US
$122.24 -10.01%
AU
$748.60 6.90%
CH